BioPharma Resources

Drugs by condition

Drugs approved for schizophrenia

Brand-name prescription drugs and biologics whose FDA label lists schizophrenia as an approved use. Matched on the label phrases: "schizophrenia".

Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations

Brand-name drugs approved

38

Still marketed, NDA or BLA

Drug classes

4

Novel drugs

16

New molecular entities and new biologics

In development

26

Investigational drugs in Phase 2 or 3

Newest approvals

The most recently first-approved brand-name drugs for schizophrenia.

  • Weltruza (Olanzapine) · Teva Oct 8, 2026
  • Bysanti (Milsaperidone) · Vanda Pharms INC NovelFeb 20, 2026
  • Cobenfy (Trospium Chloride, Xanomeline Tartrate) · Bristol-Myers NovelSep 26, 2024
  • Erzofri (Paliperidone Palmitate) · Luye Innomind Pharma Jul 26, 2024
  • Opipza (Aripiprazole) · Xiamen Lp Pharm CO Jul 22, 2024

All approved drugs for schizophrenia, by class

Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 228 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.

Atypical Antipsychotic (20)

  • Lybalvi Olanzapine, Samidorphan L-Malate · Alkermes INC · 2021
  • Caplyta Lumateperone Tosylate · Intra-Cellular · 2019
  • Vraylar Cariprazine Hydrochloride · Abbvie · 2015
  • Fanapt Iloperidone · Vanda Pharms INC · 2009
  • Invega Paliperidone · Janssen Pharms · 2006
  • Abilify Aripiprazole · Otsuka · 2002
  • Geodon Ziprasidone Hydrochloride · Viatris · 2001
  • Zyprexa Olanzapine · Cheplapharm · 1996
  • Risperdal Risperidone · Janssen Pharms · 1993
  • Clozaril Clozapine · Heritage Life · 1989
  • Opipza Aripiprazole · Xiamen Lp Pharm CO · 2024
  • Uzedy Risperidone · Teva · 2023
  • Abilify Asimtufii Aripiprazole · Otsuka · 2023
  • Secuado Asenapine · Hisamitsu · 2019
  • Rexulti Brexpiprazole · Otsuka · 2015
  • Versacloz Clozapine · Douglas Pharms · 2013
  • Zyprexa Olanzapine · Cheplapharm · 2004
  • Geodon Ziprasidone Mesylate · Viatris · 2002
  • Zyprexa Zydis Olanzapine · Cheplapharm · 2000
  • Risperdal Risperidone · Janssen Pharms · 1996

Cholinergic Muscarinic Agonist (1)

  • Cobenfy Trospium Chloride, Xanomeline Tartrate · Bristol-Myers · 2024

Central alpha-2 Adrenergic Agonist (1)

  • Igalmi Dexmedetomidine Hydrochloride · Teva · 2022

Class not listed in FDA's data (16)

Drugs in development for schizophrenia

Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.

Search the pipeline
  • KarX-ECBMS-986519, Xanomeline Enteric-coatedPhase 39 trials

    Bristol Myers Squibb · Alzheimer Disease, Alzheimer's Disease, Irritability Associated With Autism Spectrum Disorder

  • SEP-363856UlotarontPhase 37 trials

    Otsuka · Generalized Anxiety Disorder, Schizophrenia, Major Depressive Disorder

  • NBI-1117568Phase 35 trials

    Neurocrine Biosciences · Schizophrenia, Bipolar I Disorder, Mania

  • LB-102Phase 34 trials

    LB Pharmaceuticals Inc. · Schizophrenia, Bipolar I Disorder

  • HS-10380Phase 33 trials

    Jiangsu Hansoh Pharmaceutical Co., Ltd. · SCHIZOPHRENIA 1 (Disorder)

  • SPG302TazbentetolPhase 33 trials

    Spinogenix · Alzheimer Disease, Schizophrenia, Amyotrophic Lateral Sclerosis

  • OLZSAM, ALKS 3831Phase 32 trials

    Alkermes, Inc. · Bipolar I Disorder, Schizophrenia

  • B2227Phase 31 trial

    Bostal Drug Delivery Co., Ltd · Schizophrenia

  • ML-007C-MAPhase 24 trials

    MapLight Therapeutics · Psychosis Associated With Alzheimer's Disease, Schizophrenia

  • ALTO-101Phase 21 trial

    Alto Neuroscience · Schizophrenia, Cognitive Impairment

  • BR5402APhase 21 trial

    Boryung Pharmaceutical Co., Ltd · Schizophrenia

  • BR5402A-1Phase 21 trial

    Boryung Pharmaceutical Co., Ltd · Schizophrenia

  • BR5402BPhase 21 trial

    Boryung Pharmaceutical Co., Ltd · Schizophrenia

  • BR5402B-1Phase 21 trial

    Boryung Pharmaceutical Co., Ltd · Schizophrenia

  • BR5402CPhase 21 trial

    Boryung Pharmaceutical Co., Ltd · Schizophrenia

  • BR5402C-1Phase 21 trial

    Boryung Pharmaceutical Co., Ltd · Schizophrenia

  • BR5402DPhase 21 trial

    Boryung Pharmaceutical Co., Ltd · Schizophrenia

  • BR5402D-1Phase 21 trial

    Boryung Pharmaceutical Co., Ltd · Schizophrenia

  • GXV813Phase 21 trial

    Novartis · Schizophrenia

  • KYN-5356Phase 21 trial

    Kynexis B.V. · Cognitive Impairment Associated With Schizophrenia (CIAS)

2 discontinued brand-name drugs whose label still names it

More on schizophrenia: recruiting trials · published research

Related in psychiatry: Depression (major depressive disorder) · Bipolar disorder · ADHD · Anxiety disorders · Insomnia · Opioid use disorder · Alcohol dependence · Smoking cessation · PTSD · Postpartum depression

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.